NEW for 2010 - Join us for a panel session with our esteemed Advisory Board. The discussion will focus on the latest technological developments and challenges facing the biomedical device industry.
		Dr. Peter Chen Founder Irvine Biomedical, Inc. (IBI), a St. Jude Medical Company Dr. Peter Chen has more than 25 years of experience in the medical device industry. He is the Founder of Irvine Biomedical , Inc. ( IBI), a St. Jude Medical Company. Dr. Chen established IBI in 1995, and had successfully led the Company to develop, launch, and market electrophysiology products around the world. He was able to grow IBI into a multi-million dollar company before being acquired by St. Jude Medical, one of the largest global medical device companies, in 2004. After the acquisition, Dr. Chen continued his position as the President of IBI and led the company to increase its business at 33% annually and to generate a revenue of over $110 million in 2008. Dr. Chen is well known in the field of Electrophysiology and Cardiac Rhythm Management through his innovative invention of new devices for treating cardiac arrhythmias. He is the author and co-author of more than 15 patents and 20 publications. In 2009, Dr. Chen was named as the President of a newly created division, Center for Innovation and Strategic Collaboration, a corporate research and development center of St. Jude medical. Dr. Chen obtained his Master degree in Electrical Engineering from the University of Kansas and earned his Ph.D. degree in Biomedical Engineering from Rutgers, the State University of New Jersey. Prior to founding IBI, Dr. Chen held several key R & D positions in some of the major medical device companies including Baxter Health Care, Guidant Corp, Chiron and Johnson & Johnson. Dr. Chen was named twice in the 2006-2007 Strathmore's WHO's Who. He was also named as Honorary Chairman, Business Advisory Council of The National Republic Congressional Committee in 2003 and 2007.
		Steven C. George, MD, PhD Edwards Lifesciences Professor Director, Edwards Lifesciences Center for Advanced Cardiovascular Technology University of California, Irvine Dr. George received his bachelors degree in chemical engineering in 1987 from Northwestern University, M.D. from the University of Missouri School of Medicine in 1991, and Ph.D. from the University of Washington in chemical engineering in 1995. He then joined the faculty at the University of California, Irvine. His research interests include tissue engineering and pulmonary gas exchange with particular interest in vascularizing implantable tissues, linking optical and mechanical properties in fibrosis, physiological systems modeling, and exhaled nitric oxide in asthma. His research program is currently supported by the National Institutes of Health, and has previously been recognized by the NIH FIRST award in 1998 and the CAREER and Presidential Early Career Award for Scientists and Engineers (PECASE) from the National Science Foundation in 1999. He became the Director of the Center for Biomedical Engineering in October, 2000, and served as the Principal Investigator of the Development Award from the Whitaker Foundation from 2000-2006. He was elected a fellow in the American Institute of Medical and Biological Engineering (AIMBE) in 2007, and has published more than 60 peer-reviewed manuscripts. He was the founding William J. Link Professor and Chair of the Department of Biomedical Engineering at UCI from 2002-2009, and most recently was appointed as the Edwards Lifesciences Professor and Director of the new Edwards Lifesciences Center for Advanced Cardiovascular Technology.
		Michael J. Heller, Ph.D University of California, San Diego Professor Michael J. Heller began his position at University of California, San Diego in July 2001. He has a joint appointment between the department's of Bioengineering and Nanoengineering (NE). His experience (academic and industrial) includes many areas of biotechnology and biomedical instrumentation, with particular expertise in DNA synthesis, DNA molecular diagnostics and optoelectronic based detection technologies. Dr. Heller has been the co-founder of three high-tech companies: Nanogen, Nanotronics and Integrated DNA Technologies. Dr. Heller's most recent work involved the development of an integrated microelectronic array based system for genotyping, genetic and infectious disease diagnostics, protein analysis, cell separations and for nanofabrication applications. Dr. Heller has a respectable publication record, and has been an invited speaker to a large number of scientific conferences and meetings related to DNA microarrays, biosensors, lab-on-a-chip devices, bio-MEMS and nanotechnology. He has over 45 issued US patents related to microelectronic chips, microarrays and integrated devices for DNA hybridization, miniaturized sample to answer diagnostic devices, biosensors, genomics, proteomics, nanotechnology and nano-fabrication, nano-based DNA optical storage and for fluorescent energy transfer in DNA nanostructures. Dr. Heller has been a panel member for the NAS (NAE) Review of National Nanotechnology Initiative 2001-2002; the NAS (NAE) - Engineer for the 2020 - 2001/2002; the White House (OSTP) National Nanotechnology Initiative 1999/2000; and has also been involved in a number of NSF Nanotechnology Workshops.
		Charles David Rosen, M.D. Clinical Professor of Surgery University of California, Irvine, College of Medicine Charles Rosen is a board certified orthopaedic spinal surgeon and Clinical Professor of Surgery at the University of California, Irvine, College of Medicine where he practices and teaches full time. He is the founding Director of the UCI Spine Center started in 2002. In 2006 he founded the Association for Ethics in Spine Surgery which now has almost 200 spine surgeon members and for which he serves as president. A deep abiding respect for the ethical practice of medicine in relation to differing goals of industry in medicine led him to begin the Association as an outlet for the surgeons who are tired of unanswered conflicts of interest. As a result of the desire of many other non-surgeon physicians to join, he began the Association for Medical Ethics ( EthicalDoctor.org) to allow any health care practitioner to join. Dr. Rosen is a physician deeply concerned about health care in this country. The influence of industry in medicine has diverted critical resources from improving medical care to increasing industrial profit. He hopes to have a positive impact on this and other problems by improving the quality of expenditure of the health care dollar, and increasing access to medical care for the 40 million uninsured United States citizens. He lives in Manhattan Beach, California, with his wife, Elizabeth B. Lippincott, and their three children.
		Stanton J. Rowe Corporate Vice President, Advanced Technology and Chief Scientific Officer Edwards Lifesciences Corporation Stanton J. Rowe is Corporate Vice President, Advanced Technology & Chief Scientific Officer at Edwards Lifesciences Corporation. He previously served as president and CEO of Percutaneous Valve Technology Inc., which was acquired by Edwards in January 2004. Prior to PVT, which he helped to found in 1999, Rowe was corporate vice president of Business Development and Strategic Planning for Datascope Corp. Prior to this, he was vice president of Business Development for Johnson & Johnson's Interventional Systems Division (JJIS), responsible for the company's coronary stent development efforts. At JJIS and the related Cordis Corporation, Rowe held a variety of positions with increasing levels of responsibility, including heading the company's Business Development, Advanced Technology, Worldwide Clinical Research, and Marketing groups. Rowe joined Cordis after having held several positions in product management for various medical device companies. He holds a bachelor's degree from the University of Alabama. He also sits on the board of directors of both ePacing and Biomerix Corporation.
		Jerome Schultz Director, Center for Bioengineering Research UC Riverside Jerome Schultz received his B.S. and M.S in Chemical Engineering from Columbia University, and his Ph.D. in Biochemistry from the University of Wisconsin in 1958. He started his career in the pharmaceutical industry (Lederle Laboratories) then joined the University of Michigan, where he was Chairman of the Department of Chemical Engineering. He spent two years at the National Science Foundation as Deputy Director of the Engineering Centers Program. In 1987 he joined the University of Pittsburgh as Director of the Center for Biotechnology and Bioengineering, and was the Founding Chairman of the Department of Bioengineering, a nationally ranked degree program in Bioengineering. He recently spent a year at NASA's Ames Research Center as a Senior Scientist in their Fundamental Biology Program. In 2004 Dr. Schultz joined the faculty at the UC Riverside to and founded the Department of Bioengineering its undergraduate and graduate degree programs, he also serves as the Director of the newly formed Center for Bioengineering Research. He is a member of the National Academy of Engineering, a Fellow of the American Association for the Advancement of Sciences, Fellow of the Biomedical Engineering Society, Editor of Biotechnology Progress, and was a founding Fellow and President of the American Institute for Medical and Biological Engineering.
		Kalyanam Shivkumar, M.D., Ph.D University of California, Los Angeles Dr. Kalyanam Shivkumar received his medical degree from the University of Madras, India in 1991 and his PhD from UCLA in 2000. He completed his cardiology fellowship training at the University of California, Los Angeles, and upon completion of his training joined the faculty at University of Iowa as the Associate Director of Cardiac Electrophysiology. In 2002, he was recruited back to UCLA as the Director of the newly created UCLA Cardiac Arrhythmia Center at the David Geffen School of Medicine at UCLA. His field of specialization is interventional cardiac electrophysiology and he heads a group at UCLA that is involved in developing innovative techniques for the non-pharmacological management of cardiac arrhythmias. Dr. Shivkumar is certified by the American Board of Internal Medicine in the subspecialties of Cardiovascular Disease and Clinical Cardiac Electrophysiology. He holds memberships in several professional organizations, including the American Heart Association, American College of Cardiology and the Heart Rhythm Society. Dr. Shivkumar's clinical work deals with catheter ablation of complex arrhythmias and his research works deals with mechanisms of cardiac arrhythmias. He also serves as a peer reviewer for several clinical and basic journals in cardiology.
		K. Kirk Shung Professor of Biomedical Engineering University of Southern California, Los Angeles, CA K. Kirk Shung has been a Professor of Biomedical Engineering at University of Southern California, Los Angeles, CA, since 2002. He directs a NIH Resource on Medical Ultrasonic Transducer Technology since 1997. Dr. Shung is a fellow of the Institute of Electrical and Electronic Engineers (IEEE), the Acoustical Society of America and the American Institute of Ultrasound in Medicine. He is a founding fellow of the American Institute of Medical and Biological Engineering. He received the IEEE Engineering in Medicine and Biology Society early career achievement award in 1985 and was the coauthor of a paper that received the best paper award for IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control (UFFC) in 2000. He was the recipient of an outstanding alumnus award from National Cheng Kung University in Taiwan, in 2001. He was the distinguished lecturer for the IEEE UFFC society for 2002-2003. He received the outstanding research award for senior faculty at the Viterbi School of Engineering, USC in 2008. He has been selected to receive the Joseph Holmes Pioneer Award in Basics Sciences of the American Institute of Ultrasound in Medicine in March, 2010. Dr. Shung has published more than 300 papers and book chapters. He is the author of three books "Principles of Medical Imaging" published by Academic Press in 1992, "Diagnostic Ultrasound: Imaging and Blood Flow Measurements" published by CRC press in 2005, and "Ultrasonic Scattering by Biological Tissues" published by CRC Press in 1993. Dr. Shung's research interest is in ultrasonic transducers, high frequency ultrasonic imaging, and ultrasonic scattering in tissues.
		Erik van der Burg Chairman/CTO Siesta Medical, Inc. Erik is Chairman, CTO and Co-founder of Siesta Medical, which is developing surgical treatments for obstructive sleep apnea. Prior to his current role, Erik co-founded and served as CEO of Ross Creek Medical (acquired by Stryker). Ross Creek developed novel soft tissue fixation technologies that are designed to improve the strength and simplicity of the reattachment of soft tissue to bone. Prior to Ross Creek, he was co-founder and CEO of Aspire Medical, which focused on developing novel surgical therapies for obstructive sleep apnea. Previously, Erik was co-founder and Vice President of Research and Development for Appriva Medical (acquired by ev3, Inc.), where he led the development of a novel device and procedure for preventing stroke associated with atrial fibrillation. Erik also served as Director of R&D at Prograft Medical (acquired by WL Gore and Assoc.) and held engineering management positions at MicroFlow Analytical and Advanced Cardiovascular Systems (now part of Abbott Vascular). Erik holds a B.S.M.E. from Cal Poly University, San Luis Obispo, and an M.S.M.E. from Santa Clara University.